European Journal of Chemistry

Simultaneous determination of miconazole and hydrocortisone or mometasone using reversed phase liquid chromatography



Main Article Content

Ramzia Ismail El-Bagary
Ehab Farouk Elkady
Marwa Hosny Tammam
Ayman Abo Elmaaty

Abstract

Two simple, rapid and precise reversed phase liquid chromatographic methods have been developed and validated for the simultaneous determination of miconazole nitrate in two binary mixtures, with hydrocortisone acetate (Mixture 1) and mometasone furoate (Mixture 2). For the two mixtures, chromatographic separation was carried out on a C18 column. For mixture 1, a mobile phase consisting of 2.22 mM sodium dihydrogen phosphate (Triethylamine 0.2%):acetonitrile (45:55, v:v) at a flow rate of 0.9 mL/min was used at ambient temperature. Quantitative determination of miconazole and hydrocortisone was achieved with UV detection at 215 and 245 nm, respectively. Linearity, accuracy and precision were found to be acceptable over the concentration range of 30-80 μg/mL for miconazole and 4-80 μg/mL for hydrocotisone. For mixture 2, a mobile phase consisting of acetonitrile:water (Triethylamine 0.2%) (70:30, v:v) at a flow rate of 0.9 mL/min was used at ambient temperature. Quantitative determinations of miconazole and mometasone were achieved with UV detection at 215 and 250 nm, respectively. Linearity, accuracy and precision were found to be acceptable over the concentration range of 10-200 μg/mL for miconazole and 2-60 μg/mL for mometasone. The optimized methods were proved to be specific, robust and accurate for the quality control of the cited drugs in pharmaceutical preparations.

3_4_421_425_800


icon graph This Abstract was viewed 2038 times | icon graph Article PDF downloaded 1030 times

How to Cite
(1)
El-Bagary, R. I.; Elkady, E. F.; Tammam, M. H.; Elmaaty, A. A. Simultaneous Determination of Miconazole and Hydrocortisone or Mometasone Using Reversed Phase Liquid Chromatography. Eur. J. Chem. 2012, 3, 421-425.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. Reynolds, J. E. F. The extra pharmacopeia, 37th edition, Volume A, 2011.

[2]. O'Neil, M. J. The Merck Index 14th edition, An Encyclopedia of Chemicals, Drugs and Biologicals, 2006.

[3]. Erk, N.; Altun, M. L. J. Pharm. Biomed. Anal. 2001, 25(1), 115-122.
http://dx.doi.org/10.1016/S0731-7085(00)00485-4

[4]. Khashaba, P. Y.; El-Shabouri, S. R.; Emara, K. M.; Mohamed, A. M. J. Pharm. Biomed. Anal. 2000, 22(2), 363-376.
http://dx.doi.org/10.1016/S0731-7085(99)00280-0

[5]. Goger, N. G.; Gokcen, L. Anal. Lett. 1999, 32(13), 2595-2602.
http://dx.doi.org/10.1080/00032719908542990

[6]. Wrobel, K.; De-la-Garza-Rodriguez, I. M.; Lopez-de-Alba, P. L.; Lopez-Martinez, L. J. Pharm. Biomed. Anal. 1999, 20(1-2), 99-105.
http://dx.doi.org/10.1016/S0731-7085(98)00313-6

[7]. El-Shabouri, S. R.; Emara, K. M.; Khashaba, P. Y.; Mohamed, A. M. Anal. Lett. 1998, 31(8), 1367-1385.
http://dx.doi.org/10.1080/00032719808002873

[8]. Erk, N. STP. Pharma. Sci. 1996, 6(37), 312-315.

[9]. Chen, B. Zhongguo Yiyao Gongye Zazhi 1993, 24(7), 318-319.

[10]. Cavrini, V.; Di-Pietra, A. M.; Gatti, R. J. Pharm. Biomed. Anal. 1989, 7(12), 1535-1543.
http://dx.doi.org/10.1016/0731-7085(89)80162-1

[11]. Cavrini, V.; Di-Pietra, A. M.; Raggi, M. A. Pharm. Acta. Helv. 1981, 56(6), 163-165.
PMid:7255504

[12]. Huang, Q. X.; Yu, Y. Y.; Tang, C. M.; Peng, X. Z. J. Chromatogr. A. 2010, 1217(21), 3481-3488.
http://dx.doi.org/10.1016/j.chroma.2010.03.022
PMid:20381052

[13]. Moradi, M.; Yamini, Y.; Vatanara, A.; Saleh, A.; Hojati, M.; Seidi, S. Anal. Methods 2010, 2(4), 387-392.
http://dx.doi.org/10.1039/b9ay00226j

[14]. DeZan, M. M.; Camara, M. S.; Robles, J. C.; Kergaravat, S. V.; Goicoechea, H. C. Talanta 2009, 79(3), 762-767.
http://dx.doi.org/10.1016/j.talanta.2009.04.060
PMid:19576442

[15]. Ali, I.; AboulEnein, H. Y.; Gaitonde, V. D.; Singh, P.; Rawat, M. S. M.; Sharma, B. Chromatographia 2009, 70(1/2), 223-227.
http://dx.doi.org/10.1365/s10337-009-1106-z

[16]. Zhong, W.; Tang, X.; Wu, Q. J. Yaowu Fenxi Zazhi 2006, 26(9), 1305-1307.

[17]. Cakar, M.; Popovic, G.; Agbaba, D. J. Aoac. Int. 2005, 88(5), 1544-1548.

[18]. Cirilli, R.; Ferretti, R.; Gallinella, B.; La-Torre, F.; La-Regina, G.; Silvestri, R. J. Sep. Sci. 2005, 28(7), 627-634.
http://dx.doi.org/10.1002/jssc.200400102
PMid:15912731

[19]. Aboul-Enein, H. Y.; Ali, I. J. Pharm. Biomed. Anal. 2002, 27(3-4), 441-446.
http://dx.doi.org/10.1016/S0731-7085(01)00575-1

[20]. Aboul-Enein, H. Y.; Ali, I. Chromatographia 2001, 54(3-4), 200-202.
http://dx.doi.org/10.1007/BF02492245

[21]. Aboul-Enein, H. Y.; Ali, I. FreseniusJ. Anal. Chem. 2001, 370(7), 951-955
http://dx.doi.org/10.1007/s002160100884
PMid:11569882

[22]. Indrayanto, G.; Widjaja, S.; Sutiono, S. J. Liq. Chromatogr. Relat. Technol. 1999, 22(1), 143-152.
http://dx.doi.org/10.1081/JLC-100101650

[23]. Morin, N.; Guillaume, Y. C.; Rouland, J. C. Chromatographia 1998, 48(5-6), 388-394.
http://dx.doi.org/10.1007/BF02467709

[24]. Han, J.; Zeng, H. J.; Tang, H. F. Yaowu Fenxi Zazhi 1997, 17(1), 9-11.

[25]. Kobylinska, M.; Kobylinska, K.; Sobik, B. J. Chromatogr. B: Biomed. Appl. 1996, 685(1), 191-195.
http://dx.doi.org/10.1016/0378-4347(96)00125-9

[26]. Roychowdhury, U.; Das, S. K. J. Aoac. Int. 1996, 79(3), 656-658.

[27]. Zhang, S.; Luo, S.; Zhang, F.; Cai, H.; Yin, W. Yaowu Fenxi Zazhi 1993, 13(3), 198-199.

[28]. Tyler, T. A.; Genzale, J. A. J. Assoc. Off. Ana. Chem. 1989, 72(3), 442-444.

[29]. Selinger, K.; Matheou, D.; Hill, H. M. J. Chromatogr. 1988. 434, 259-264.
http://dx.doi.org/10.1016/0378-4347(88)80085-9

[30]. Hosotsubo, H. Chromatographia 1988, 25(8), 717-720
http://dx.doi.org/10.1007/BF02290478

[31]. Blanco, M.; Coello, J.; Iturriaga, H.; Maspoch, S.; Villegas, N. Analyst 1999, 124(6), 911-915.
http://dx.doi.org/10.1039/a900856j

[32]. Bonazzi, D.; Andrisano, V.; Gatti, R.; Cavrini, V. J. Pharm. Biomed. Anal. 1995, 13(11), 1321-1329.
http://dx.doi.org/10.1016/0731-7085(95)01536-T

[33]. Nikolic, K.; Medenica, M.; Bogavac, M.; Arsenijevic, L. Farmaco 1991, 46(4), 623-626.
PMid:1930555

[34]. Walash, M. I.; Zakhari, N. A.; Rizk, M.; Toubar, S. Farmaco 1987, 42(3), 81-90.

[35]. Rizk, M.; Zakhari, N.; Toubar, S.; Walash, M. I. Acta Pharm. Fenn. 1984, 93(3), 129-134.

[36]. Zuo, Z. H.; Tang, S. F. Yaowu Fenxi Zazhi 2010, 30(8), 1516-1519.

[37]. Chauhan, V.; Conway, B. Chromatographia 2005, 61(11-12), 555-559.
http://dx.doi.org/10.1365/s10337-005-0555-2

[38]. Zuo, Z. H.; Zhou, J. M.; Zuo, W. U. Yaowu Fenxi Zazhi 2004, 24(4), 420-421.

[39]. Hajkova, R.; Solich, P.; Dvorak, J.; Sicha, J. J. Pharm. Biomed. Anal. 2003, 32(4-5), 921-927.
http://dx.doi.org/10.1016/S0731-7085(03)00193-6

[40]. Lemus-Gallego, J. M.; Perez-Arroyo, J. Anal. Bioanal. Chem. 2002, 374(2), 282-288.

[41]. Ku, Y. R.; Wen, K. C.; Ho, L. K.; Chang, Y. S. Yaowu Shipin Fenxi 1999, 7(2), 123-130.

[42]. Reubsaet, J. L. E.; Vieskar, R. J. Chromatogr. A. 1999, 841(2), 147-154.
http://dx.doi.org/10.1016/S0021-9673(99)00253-8

[43]. Valenta, C.; Janout, H. J. Liq. Chromatogr. 1994, 17(5), 1141-1146.
http://dx.doi.org/10.1080/10826079408013391

[44]. Bhounsule, G. J.; Gorule, V. S.; Patil, G. V. Indian Drugs 1992, 29(13), 594-597.

[45]. Hailey, D. M.; Lea, A. R. J. Assoc. Off. Ana. Chem. 1981, 64(4), 870-874.

[46]. Mousa, B. A.; El-Kousy, N. M.; El-Bagary, R. I.; Mohamed, N. G. Chem. Pharm. Bull. 2008, 56(2), 143-149.
http://dx.doi.org/10.1248/cpb.56.143

[47]. Di-Pietra, A. M.; Andrisano, V.; Gotti, R.; Cavrini, V. J. Pharm. Biomed. Anal. 1996, 14(8-10), 1191-1199.
http://dx.doi.org/10.1016/0731-7085(95)01695-3

[48]. Shaikh, S.; Muneera, M. S.; Thusleem, O. A.; Tahir, M.; Kondaguli, A. V. J. Chromatogr. Sci. 2009, 47(2), 178-183.

[49]. Sahasranaman, S.; Tang, Y. F.; Biniasz, D.; Hochhaus, G. J. Chromatogr. B. 2005, 819(1), 175-179.
http://dx.doi.org/10.1016/j.jchromb.2005.01.018
PMid:15797536

[50]. Wulandari, L.; Sia, T. K.; Indrayanto, G. Liq. Chromatogr. Relat. Technol. 2003, 26(1), 109-117.
http://dx.doi.org/10.1081/JLC-120017156

[51]. Teng, X. W.; Foe, K.; Brown, K. F.; Cutler, D. J.; Davies, N. M. J. Pharm. Biomed. Anal. 2001, 26(2), 313-319.
http://dx.doi.org/10.1016/S0731-7085(01)00408-3

[52]. Spangler, M. Supelco. Rep. 1994, 13(2), 12-13.

[53]. The European Agency for the Evaluation of Medical Products, ICH Topic Q2B Note for Guidance on Validation of Analytical Procedures, Methodology GPMP/ICH/281/95, 1996.

[54]. The United States Pharmacopeial Convention, Thirty-Fourth Revision, NF29, 2011.

[55]. British pharmacopeia. The stationary office, medical and pharmaceutical substances, London, 2011.

Supporting Agencies

Most read articles by the same author(s)

Most read articles by the same author(s)

TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).